• linkedin
  • Increase Font
  • Sharebar

    Use of observation for PCa varies widely among urologists

    Analyses of data on the management of localized prostate cancer reveal individual providers vary substantially in their use of observation for men with low-risk disease. More importantly, the research also shows a statistically significant positive correlation at the provider level in the predictive probabilities of observation for managing low-risk and high-risk disease.  

    Also see: Water ablation’s safety, efficiency in BPH assessed

    In other words, it determined that urologists tend to use observation or treatment for localized prostate cancer, regardless of disease risk.

    The study was reported by investigators from Vanderbilt University Medical Center, Nashville, TN at the AUA annual meeting in San Diego.

    Mark D. Tyson, MDDr. Tyson“These findings suggest that when the Centers for Medicare & Medicaid Services rolls out measures for the Merit-Based Incentive Payment System (MIPS) to limit inappropriate resource use for men with low-risk localized prostate cancer, it will be important to do more than simply mandate a standard resource-use pattern of observation because it may impede access to care for high-risk patients,” said first author Mark D. Tyson, MD.

    “We suggest that a quality measure needs to be bidirectional, specifying a rate of observation for low-risk disease and a rate of treatment for high-risk disease,” he told Urology Times.

    Have you read - Dusting vs. basketing: Which method is better?

    Individual urologist use of observation for men with localized prostate cancer was quantified by linking data from the Surveillance, Epidemiology, and End-Results program to Medicare claims data, recognizing that MIPS quality and resource use measures will be derived from claims-based data, Dr. Tyson told Urology Times.

    Next: Study included data from 57,669 patients


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available